TearLab readies overhaul of dry eye market

In the 1990s, Elias Vamvakas turned TLC Laser Vision into a medical success story, freeing hundreds of thousands of people from wearing glasses and contact lenses.  Now, he’s back at the helm of San Diego-based TearLab (NASDAQ:TEAR; TSX:TLB)) with a groundbreaking diagnostic test for dry eye disease or DED. “While laser vision correction surgery was [...]

TearLab technology validated in peer-review journal

TearLab’s (NASDAQ:TEAR;TSX:TLB) point-of-care osmolarity test is the technology of choice to aid in the diagnosis of Dry Eye Disease (“DED”) according to a peer-reviewed article published in the current issue of Contact Lens & Anterior Eye, the official journal of the British Contact Lens Association. The article states that while tear osmolarity has proven to [...]